Price T Rowe Associates Inc Enzo Biochem Inc Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Enzo Biochem Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 44,800 shares of ENZ stock, worth $46,144. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,800
Previous 44,800
-0.0%
Holding current value
$46,144
Previous $49,000
4.08%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ENZ
# of Institutions
48Shares Held
15.5MCall Options Held
2.3KPut Options Held
0-
Harbert Fund Advisors, Inc. Birmingham, AL5.18MShares$5.33 Million3.43% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.53MShares$2.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$1.93 Million0.0% of portfolio
-
Potomac Capital Management, Inc.1.48MShares$1.53 Million3.63% of portfolio
-
Viex Capital Advisors, LLC Sunny Isles Beach, FL1.33MShares$1.37 Million9.62% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $50.2M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...